BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
101 – 110 of 3089
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Genetic profiling of a chondroblastoma-like osteosarcoma/malignant phosphaturic mesenchymal tumor of bone reveals a homozygous deletion of CDKN2A, intragenic deletion of DMD, and a targetable FN1-FGFR1 gene fusion
(
- Contribution to journal › Article
-
Mark
Elevated Platelet Count Appears to Be Causally Associated with Increased Risk of Lung Cancer: A Mendelian Randomization Analysis
2019) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 28(5). p.935-942(
- Contribution to journal › Article
-
Mark
Microbubbles as a contrast agent in grating interferometry mammography: an ex vivo proof-of-mechanism study
2019) In European Radiology Experimental(
- Contribution to journal › Article
-
Mark
Incidental metastases and lymphoma of the gallbladder–an analysis of ten rare cases identified from a large national database
(
- Contribution to journal › Article
-
Mark
Reducing recurrence in non-muscle-invasive bladder cancer by systematically implementing guideline-based recommendations : effect of a prospective intervention in primary bladder cancer patients
(
- Contribution to journal › Article
-
Mark
Population-based primary HPV mRNA cervical screening compared with cytology screening
(
- Contribution to journal › Article
-
Mark
Agreement between patient reported outcomes and clinical reports after radical prostatectomy - A prospective longitudinal study
(
- Contribution to journal › Article
-
Mark
Wnt5a is a TLR2/4-ligand that induces tolerance in human myeloid cells
(
- Contribution to journal › Article
-
Mark
New Hope in Prostate Cancer Precision Medicine? miRNA Replacement and Epigenetics
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Preserving Preclinical PET Quality During Intratherapeutic Imaging in Radionuclide Therapy with Rose Metal Shielding Reducing Photon Flux
(
- Contribution to journal › Article